Study S001744

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Ecnoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

ClinicalTrials.gov record

Registration

Registration: NCT07734311
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: RECRUITING
Enrollment: 360
Start: 2026-08-03
Primary completion: 2028-05-31
Lead sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Conditions: Knee Osteoarthritis; Obesity
Interventions: DRUG:Ecnoglutide Injection; DRUG:placebo with matching volume
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score [Baseline, week 68]
Percentage Change in Body Weight [Baseline, week 68]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.